195 related articles for article (PubMed ID: 33139621)
1. Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.
Grigoriadou GΙ; Esagian SM; Ryu HS; Nikas IP
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33139621
[TBL] [Abstract][Full Text] [Related]
2. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
Song Z; Wang W; Li M; Liu J; Zhang Y
Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing in cytology specimens for molecular profiling of lung adenocarcinoma.
Zhang Y; Li J; Hua P; Liu N; Li Q; Zhu X; Jiang L; Zheng K; Su X
Int J Clin Exp Pathol; 2018; 11(7):3647-3655. PubMed ID: 31949745
[TBL] [Abstract][Full Text] [Related]
4. Molecular Profiling of Malignant Pleural Effusion in Metastatic Non-Small-Cell Lung Carcinoma. The Effect of Preanalytical Factors.
Carter J; Miller JA; Feller-Kopman D; Ettinger D; Sidransky D; Maleki Z
Ann Am Thorac Soc; 2017 Jul; 14(7):1169-1176. PubMed ID: 28557526
[TBL] [Abstract][Full Text] [Related]
5. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling.
Guo Z; Xie Z; Shi H; Du W; Peng L; Han W; Duan F; Zhang X; Chen M; Duan J; Lin J; Chen X; Lizaso AA; Han-Zhang H; He J; Yin W
Thorac Cancer; 2019 Apr; 10(4):823-831. PubMed ID: 30779318
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
[TBL] [Abstract][Full Text] [Related]
10. Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer.
Li J; Li X; Wang W; Shao Y; Zhang Y; Song Z
Transl Oncol; 2020 Aug; 13(8):100784. PubMed ID: 32428850
[TBL] [Abstract][Full Text] [Related]
11. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.
Korczyński P; Mierzejewski M; Krenke R; Safianowska A; Light RW
Pol Arch Intern Med; 2018 Jun; 128(6):354-361. PubMed ID: 29968696
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.
Whitfield HJ; Berthelet J; Mangiola S; Bell C; Anderson RL; Pal B; Yeo B; Papenfuss AT; Merino D; Davis MJ
Clin Transl Med; 2023 Sep; 13(9):e1356. PubMed ID: 37691350
[TBL] [Abstract][Full Text] [Related]
13. The Value of Cytology in the Evaluation of Malignant Pericardial Effusions: A Systematic Review.
Shartouni R; Shartouni R; Mahmoodi M; Nikas IP
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204458
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnosis and management of malignant pleural effusions.
Heffner JE; Klein JS
Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
[TBL] [Abstract][Full Text] [Related]
16. Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma.
Zhang P; Wu X; Tang M; Nie X; Li L
Thorac Cancer; 2019 Dec; 10(12):2218-2224. PubMed ID: 31602787
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens.
Liu L; Shao D; Deng Q; Tang H; Wang J; Liu J; Guo F; Lin Y; Peng Z; Mao M; Kristiansen K; Ye M; He J
J Thorac Dis; 2018 May; 10(5):2631-2637. PubMed ID: 29997924
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic molecular biomarkers for malignant pleural effusions.
Sriram KB; Relan V; Clarke BE; Duhig EE; Yang IA; Bowman RV; Lee YC; Fong KM
Future Oncol; 2011 Jun; 7(6):737-52. PubMed ID: 21675837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
